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Abstract
Microarray gene expression data sets usually contain a large number of
genes, but a small number of samples. In this article, we present a two-stage
classication model by combining feature selection with the dissimilarity-
based representation paradigm. In the preprocessing stage, the ReliefF al-
gorithm is used to generate a subset with a number of top-ranked genes; in
the learning/classication stage, the samples represented by the previously
selected genes are mapped into a dissimilarity space, which is then used to
construct a classier capable of separating the classes more easily than a
feature-based model. The ultimate aim of this paper is not to nd the best
subset of genes, but to analyze the performance of the dissimilarity-based
models by means of a comprehensive collection of experiments for the clas-
sication of microarray gene expression data. To this end, we compare the
classication results of an articial neural network, a support vector machine
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and the Fisher's linear discriminant classier built on the feature (gene) space
with those on the dissimilarity space when varying the number of genes se-
lected by ReliefF, using eight dierent microarray databases. The results
show that the dissimilarity-based classiers systematically outperform the
feature-based models. In addition, classication through the proposed rep-
resentation appears to be more robust (i.e. less sensitive to the number of
genes) than that with the conventional feature-based representation.
Keywords: Gene expression, Dissimilarity space, Feature selection,
Classication.
1. Introduction
Microarray biotechnology is able to record and monitor the expression
levels of thousands of genes simultaneously within a few dierent samples,
which has led to a growing interest for its application to a broad variety
of biological and biomedical problems. Microarray gene expression data has
extensively been applied to distinguish between cancerous and normal tissues,
to classify dierent types or subtypes of tumors, and also to predict the
response to a particular therapeutic drug and the risk of relapse [2, 22, 30, 40].
In the literature, one can nd a plethora of machine learning models that
have been used for microarray gene expression analysis and prediction, such
as support vector machines, K nearest neighbors, decision trees, Bayesian
models, articial neural networks, and classier ensembles [3, 11, 15, 25, 32,
42]. A review of computational intelligence techniques applied to various
biomedical problems can be found in the paper by Hassanien et al. [14].
All these methods have been dened to be used in a feature space, but other
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alternative spaces, which have been reported to be truly eective on a number
of real-life problems, could also be exploited for biomedical applications. One
of these alternatives is the dissimilarity space, which constitutes the target
of the present work.
In the dissimilarity-based classication paradigm [26], samples to be clas-
sied are encoded using pairwise dissimilarities (distances from other samples
in the data set). The justication for constructing classiers in a dissimilarity
space is that a dissimilarity measure should be small for similar samples and
large for distinct samples, thus allowing for ecient and reliable discrimina-
tion of classes. Another important characteristic is that the dimensions of a
dissimilarity space symbolize homogeneous types of information and there-
fore all dimensions can be considered as equally relevant. On the other hand,
for a complex problem, a simple linear classication model in a dissimilarity
space could separate the classes more easily than the same classier in a
feature space [29]. The dissimilarity-based approach has been applied suc-
cessfully to many elds, such as computer vision, medical imaging and remote
sensing [35, 38] but, to the best of our knowledge, not yet to biomedicine.
However, classication using microarray data poses a major computa-
tional challenge due to the very high number of genes (G) and the low
number of samples (n) [10]. Typically, the number of genes is of the or-
der of thousands while the number of samples is less than a hundred. This
phenomenon is referred to as the `large G, small n' or `curse of dimensional-
ity' problem in statistics, which increases the complexity of the classication
task considerably, degrades the generalization ability of classiers and hin-
ders the understanding of the relationships among the genes and the tissue
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samples [9, 31]. The common practice to tackle this problem is using some
form of feature (gene) selection as a preprocessing step to be applied be-
fore building the classier. Gene selection allows the removal of irrelevant,
noisy and redundant genes from microarray data, thus preserving the genes
that best discriminate biological samples of dierent types (tissue categories,
disease states or clinical outcomes).
Among the most successful gene selection methods are those based on
gene ranking or scoring [17, 20, 34, 41]. In this case, each gene is evaluated
individually and assigned a score reecting its correspondence with the class
according to certain predetermined criteria. Afterwards, genes are ranked
by their scores and a number of the top-ranked ones, which can be deemed
as the most informative genes, are chosen. In practice, the gene ranking
algorithms are lters that compute some measure to determine how much
more signicant each gene is than the others [13]. Some well-established
score-based methods include the t-test, the non-parametric Kruskal-Wallis
statistic, the Welch test statistic, information-theoretic measures, Kendall's
correlation coecient, 2-statistic and ReliefF, among others.
In the present study, we propose a method to classify the microarray
data using a dissimilarity space together with the selection of a number of
top-ranked genes through the ReliefF algorithm. Here we have adopted the
ReliefF algorithm because of its simplicity and good performance in microar-
ray data analysis [5, 39], but other methods could be applied as well [6, 36].
Hence, instead of working with genes directly, the samples are dened by
pairwise dissimilarity vectors because our hypothesis is that the samples that
belong to a same class should share similar information and specicities re-
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lated to the problem under study. We are, then, investigating the feasibility
and eciency of the new method by comparing the performance of models
built both on dissimilarity and feature spaces using an articial neural net-
work, the Fisher's linear discriminant and a support vector machine for the
classication of eight benchmarking microarray gene expression databases.
Note that our purpose here is not to nd the best subset of genes or the best
performing classier, but we are trying to gain some insight into the perfor-
mance of the dissimilarity-based classication models applied to microarray
gene expression data.
The rest of this article is organized as follows. Section 2 presents the
details of the two-stage method proposed here, including a description of
the ReliefF algorithm and the bases of the dissimilarity-based classication
approach. The experimental databases and set-up are given in Section 3.
Section 4 discuss the results. Finally, Section 5 summarizes the most inter-
esting conclusions drawn from this study and provides possible directions for
future research.
2. Methods
In this section, we provide a description of the two methods that com-
prise the procedure for classication of microarray gene expression data: the
ReliefF algorithm for gene selection and the dissimilarity space approach to
classication. A general overview of the complete process for both building
the model and classifying the test samples is also included.
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2.1. Gene selection with ReliefF
ReliefF is an improved version of the Relief procedure to estimate the
quality of features in problems with strong dependencies between features [18,
33]. The basic idea of the ReliefF algorithm lies on adjusting the weights of
a vector W = [w(1); w(2); : : : ; w(G)] to give more relevance to features that
better discriminate the samples from neighbors of dierent class.
It randomly picks out a sample x and searches for K nearest neighbors of
the same class (hits, hj) and K nearest neighbors from each of the dierent
classes (misses, mj). If x and hj have dierent values on gene f , then the
weight w(f) is decreased because it is interpreted as a bad property of this
gene. In contrast, if x and mj have dierent values on the gene f , then w(f)
is increased. The whole process is repeated t times, updating the values of
the weight vector W as follows
w(f) = w(f) 
PK
j=1 dist(f; x; hj)
t K (1)
+
X
c6=class(x)
P (c)
1  P (class(x)) 
PK
j=1 dist(f; x;mj)
t K
where P (c) is the prior probability of class c, P (class(x)) denotes the prob-
ability for the class of x, and dist(f; x;mj) represents the absolute distance
between samples x and mj in the gene f .
The algorithm assigns negative values to genes that are completely irrel-
evant and the highest scores for the most informative genes. In general, one
will then select the g top-ranked features in order to build the classier with
a presumably much smaller subset of genes (g  G).
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2.2. Classication in the dissimilarity space
Traditional learning and classication methods rely on the description of
samples by means of set of observable features. An alternative to the fea-
ture space is the dissimilarity space proposed by Pekalska and Duin [26], in
which the dimensions are dened by vectors measuring pairwise dissimilari-
ties between examples and individual prototypes from an initial representa-
tion set R = fp1; : : : ; prg. This can be chosen as the complete training set
T = fx1; : : : ; xng, a set of generated prototypes, a subset of T that covers all
classes, or even an arbitrary set of labeled or unlabeled samples [28].
Given a dissimilarity measure d(; ), which is required to be nonnegative
and to obey the reexive condition (d(xi; xi) = 0) but it might be non-metric,
a dissimilarity representation is dened as a data-dependent mapping func-
tionD(; R) from T to the dissimilarity space. This means that every example
xi 2 T is represented by an r-dimensional vector in the dissimilarity space,
D(xi; R) = fd(xi; p1); : : : ; d(xi; pr)g, that is, each dimension corresponds to
a dissimilarity to a prototype from R. Therefore, dissimilarities between all
examples in T to R are represented by a matrix D(T;R) of size n r, which
corresponds to the dissimilarity representation we want to learn from [27].
D(T;R) =
26666664
d(x1; p1) d(x1; p2)    d(x1; pr)
d(x2; p1) d(x2; p2)    d(x2; pr)
...
...
. . .
...
d(xn; p1) d(xn; p2)    d(xn; pr)
37777775
In a general classication scenario, a drawback related to the use of fea-
tures is that dierent samples may have the same representation, thus result-
ing in class overlap (i.e. some samples of dierent classes are represented by
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the same feature vectors). In the dissimilarity space, however, only identical
samples (with the same class label) have a zero-distance, which means that
there does not exist class overlap.
2.3. General overview of the process
The method proposed in this article combines the ReliefF algorithm for
gene selection with the dissimilarity-based representation for classication
of microarray gene expression data. The owchart of the complete learn-
ing/classication procedure is shown in Fig. 1.
Gene ranking (ReliefF) 
Mapping function 
Build the classifier 
Training set 
(G genes) 
Training set 
(g genes) 
Classifier Output 
X (G genes) 
X (g genes) 
Figure 1: Flowchart of the proposed learning and classication methodology (red lines
correspond to the stage for building the dissimilarity space).
In the learning phase (continuous lines), the rst step consists of applying
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the ReliefF algorithm to the data set containing G genes and n samples,
whose output is a weight vector W that allows to select a subset with the
g top-ranked genes. Next, the resulting data set with the selected genes
is mapped into a dissimilarity space represented by a matrix of size n  r
(here we will take r to be equal to n). Finally, the classier is built in the
dissimilarity space just dened.
In the testing phase (dashed lines), when a new instance x has to be clas-
sied, its dimensionality is rstly reduced according to the subset of g genes
selected in the training phase. Then the sample is mapped into the dissim-
ilarity space by calculating the dissimilarity between x and all prototypes
in the representation set R, resulting in a one-dimensional matrix (vector)
D(x; R) = [d(x; p1); d(x; p2); : : : ; d(x; pr)]. This dissimilarity vector D(x; R)
is passed through the classier for yielding a class label to the new instance
x.
3. Experiments
To analyze the performance of the method, we have conducted a series
of experiments on a collection of data sets available at Kent Ridge Biomedi-
cal Data Set Repository (http://datam.i2r.a-star.edu.sg/datasets/krbd). Ta-
ble 1 provides a brief description of each data set, including the number of
genes, the number of samples and the size of each class.
The experiments have consisted of studying the classication performance
on the feature and dissimilarity spaces when varying the number of genes
selected by ReliefF from 1 to 150. Bearing in mind that the aim of this
study is to compare both representations, not to nd the optimal number
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Table 1: Characteristics of the microarray data sets.
Genes Samples Class1/Class2
Breast 24481 97 Relapse (46)/Non-relapse (51)
CNS 7129 60 Failure (39)/Survivor (21)
Colon 2000 62 Tumor (40)/Normal (22)
DLBCL-Stanford 4026 47 Germinal (24)/Activated (23)
Lung-Brigham 12533 181 MPM (31)/ADCA (150)
Lung-Michigan 7129 96 Tumor (86)/Normal (10)
Prostate 12600 136 Tumor (77)/Normal (59)
Ovarian 15154 253 Cancer (162)/Normal (91)
of genes, the experiments have been conned to the 150 top-ranked genes
because it has been observed that when the number of genes is greater than
150, the variation in accuracy is not signicant [21, 24, 37]. Although one
might achieve better results selecting a dierent number of genes for each
database, these improvements would apply equally to both representations;
hence, for the purpose of this paper, the key question is not how many genes
should be selected to perform the best with each database. Moreover, it
is important to remark that the behavior of the optimal number of genes
relative to the sample size also depends on the classier [16].
3.1. Experimental design
We have focused our study on three linear classication models, the
Fisher's linear discriminant (FLD), the support vector machine (SVM) and
the multilayer perceptron neural network (MLP) comparing their behavior
on the feature space and on the dissimilarity space after selecting a number
of top-ranked genes with the ReliefF algorithm. Therefore, combining the
classiers and the representations, we have six dierent approaches: (i) FLD
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on the feature space (FLD-F), (ii) FLD on the dissimilarity space (FLD-D),
(iii) SVM on the feature space (SVM-F), (iv) SVM on the dissimilarity space
(SVM-D), (v) MLP on the feature space (MLP-F), and (vi) MLP on the
dissimilarity space (MLP-D).
The parameter settings for the algorithms used in the experiments are
as follows. The number of nearest neighbors K for the ReliefF algorithm
has been set to 1 due to the small size of the data sets. The MLP neural
networks have used a sigmoidal transfer function and the backpropagation
learning algorithm. The SVM models have been constructed using a linear
kernel function, which has been regarded as one of the best options in many
bioinformatics applications [1], with the soft-margin constant C = 1:0. On
the other hand, due to the small size of the training data sets, we have chosen
the representation set R to be equal to the training set T (that is, r = n),
which means that the mapping function from T to the dissimilarity space
results in a square matrix of size n n.
The 10-fold cross-validation method has been adopted for the experimen-
tal design because it seems to be the best estimator of classication perfor-
mance compared to other methods, such as bootstrap with a high computa-
tional cost or re-substitution with a biased behavior [4]. Each original data
set has randomly been divided into ten stratied parts of equal (or approxi-
mately equal) size; for each fold, nine blocks have been pooled as the training
set, and the remaining part has been used as an independent test set.
3.2. Performance evaluation metrics
In most biomedical applications, it is important to assess not only the
accuracy of the model, but also false-positive and false-negative errors (or
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their counterpart, the true-negative and true-positive hits respectively) be-
cause they usually have asymmetric costs [19, 23]. Hence, the performance of
the methods has been analyzed by means of three metrics that can be easily
computed from a 2  2 confusion matrix as that shown in Table 2, where
each entry (i; j) contains the number of correct/incorrect predictions:
 Accuracy: Acc = (TP + TN)=(TP + FN + TN + FP )
 True-positive rate, which is the proportion of positive samples that are
correctly classied: TPr = TP=(TP + FN)
 True-negative rate, which is the proportion of negative cases that are
correctly classied: TNr = TN=(TN + FP )
where TP and TN denote the number of positive and negative examples
correctly classied respectively, whereas FP and FN represent the number
of misclassications on negative and positive examples respectively1.
Table 2: Confusion matrix.
Actual class
Positive Negative
Predicted class
Positive TP FP
Negative FN TN
1Note that we have considered that the samples from class1 shape the positive class
and those that belong to class2 form the negative class
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4. Results
For each database, we have rst compared the average classication accu-
racies of FLD (Fig. 2), SVM (Fig. 3) and MLP (Fig. 4) on the feature space
(blue line) with those on the dissimilarity space (red line) when using the
dierent subsets of genes. One can observe that in general, the performance
of classiers built from the dissimilarity space is superior to that of the mod-
els constructed from the feature space, especially in the case of FLD. It is
also important to note that when varying the number of genes selected, the
accuracy seems to keep more steady using the classiers on the dissimilarity
space than on the feature space. This suggests that the dissimilarity-based
models are less sensitive not only to the amount of genes selected, but also
to their quality or discriminative power. Even when the classier on the
feature space behaves better than on the dissimilarity space for the rst top-
ranked genes, as it is the case of the Breast database using about 45 genes,
its performance clearly decreases if more genes are selected.
All the performance results on the Lung-Brigham and Ovarian databases
are very similar (close to 100% of test examples have correctly been classi-
ed), regardless of the number of genes selected, the classier applied or the
representation space used. This behavior suggests that there does not exist
overlapping between classes and these are well separated in the feature space.
Under these conditions, the dissimilarity-based representation is expected to
perform equally well as or even better than the feature-based representation.
Despite dierences in the case of the FLD classier are more signicant
than using SVM, this model built on the dissimilarity space still performs
better than the feature-based SVM on most databases. The performance on
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Figure 2: Classication accuracy with the FLD classier when varying the number of genes
selected by ReliefF.
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Figure 3: Classication accuracy with the SVM when varying the number of genes selected
by ReliefF.
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Figure 4: Classication accuracy with the MLP when varying the number of genes selected
by ReliefF.
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the Lung-Michigan database appears to be the exception that conrms the
rule, since the accuracy with the dissimilarity representation suers a very
important degradation in the range between 15 and 120 selected genes when
compared to the performance using the feature space.
In general, the performance of MLP models plotted in Fig. 4 seems to
be little aected by the representation space used. While the Breast, Colon,
DLBCL-Stanford and Prostate databases present some small dierences be-
tween the accuracies on the feature space and those on the dissimilarity space,
the rest of problems show very similar results irrespective of the representa-
tion space used to build the neural networks.
Table 3: Accuracy averaged across the 150 top-ranked genes ( standard deviation) and
Friedman's average ranks for each model.
FLD-F FLD-D SVM-F SVM-D MLP-F MLP-D
Breast 0.65770.07 0.72050.03 0.70410.02 0.73290.03 0.68460.04 0.65180.04
CNS 0.59490.04 0.71660.04 0.67320.06 0.67550.05 0.66250.05 0.67070.06
Colon 0.68460.08 0.82600.02 0.74150.04 0.80850.02 0.77040.03 0.83740.03
DLBCL 0.77520.07 0.94130.03 0.94060.03 0.94340.03 0.90890.03 0.96240.03
Lung-B 0.96580.01 0.98630.01 0.98250.01 0.97500.01 0.98600.01 0.98560.01
Lung-M 0.94190.03 0.97440.02 0.96240.02 0.70410.20 0.97800.02 0.97230.02
Prostate 0.70660.06 0.90230.04 0.89320.06 0.89480.04 0.90170.05 0.87320.03
Ovarian 0.99660.01 0.99130.01 0.99410.01 0.98890.01 0.99320.01 0.98790.01
Average 0.7904 0.8823 0.8615 0.8404 0.8607 0.8677
Rank 5.125 2.000 3.625 3.375 3.250 3.625
The ndings discussed so far are supported by the results in Table 3,
which reports the accuracy averaged across the 150 top-ranked genes for
each database, the average values across all the databases and the Friedman's
average ranks for each approach (the one with the lowest average rank has to
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be viewed as the best solution). The values for the best performing method
in each database are underlined. Based on the Friedman's average ranks, the
results reveal that the FLD classier built on the dissimilarity space can be
considered as the model with the best overall performance, followed by the
SVM-D approach. What is more interesting, however, is that the feature-
based classiers have been worse in 6 out of the 8 databases (only FLD-F
applied to the Ovarian data set and MLP-F on Lung-Michigan have been
slightly superior to any other method), demonstrating the benets of using
the dissimilarity-based approaches to the classication of microarray data.
With the aim of checking whether or not the accuracy results are signi-
cantly dierent, the Iman-Davenport's statistic has been computed [7]. This
is distributed according to an F -distribution with K  1 and (K  1)(N   1)
degrees of freedom, where K denotes the number of models and N is the
total number of data sets. The p-value computed by F (5; 35) was 0.0314056,
which is less than a signicance level of  = 0:05. Therefore, the null-
hypothesis that all the approaches perform equally well can be rejected. As
the Iman-Davenports statistic only allows to gure out dierences among all
methods, we have also carried on with two post hoc tests (Holm's and Li's)
using the best classier (FLD-D) as the control algorithm [7]. Instead of the
unadjusted p-values, both post hoc tests have been used with the adjusted
p-values because these reect the probability error of a certain comparison,
but they do not disregard the familiy-wise error rate (the probability of mak-
ing one or more false discoveries among all the hypotheses when performing
multiple pairwise tests) [8, 12].
Table 4 reports the adjusted p-values calculated using the Holm's and
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Table 4: Results obtained with Holm's and Li's tests (the classiers have been sorted in
ascending order of the unadjusted p-values).
i Model z Unadjusted p-value Holm's Li's
5 FLD-F 3.340766 0.000835 0.004177 0.001020
4 SVM-F 1.737198 0.082352 0.329409 0.091411
3 MLP-D 1.737198 0.082352 0.329409 0.091411
2 SVM-D 1.469937 0.141579 0.329409 0.147458
1 MLP-F 1.336306 0.181449 0.329409 0.181449
Li's procedures. The methods which have been signicantly worse than the
control algorithm at a signicance level of  = 0:05 are highlighted in bold,
and those that reject the null-hypothesis of equivalence with the control
algorithm for  = 0:1 are underlined. The Holm's test detected signicant
pairwise dierences, revealing that the FLD-D model performs signicantly
better than the feature-based FLD and it is statistically equivalent to the
rest of methods. On the other hand, the Li's post hoc test showed that the
FLD-D scheme is signicantly better than FLD-F at a signicance level of
 = 0:05, and signicantly superior to SVM-F and MLP-D at a signicance
level of  = 0:1.
Although the aim of this work is not to choose the best performing subset
of genes, Table 5 summarizes the accuracy results achieved by each classica-
tion approach when using all the genes (that is, without feature selection) in
order to provide a baseline for comparison with the results given in Table 3.
Nonetheless, because of a lack of memory capacity in our machine, it has not
been possible to report the results of the MLP models for this experiment;
therefore, we have restricted the analysis to the cases of FLD and SVM. An
interesting observation is that the feature-based classiers have performed
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better by using the whole set of genes than with a subset of genes, whereas
the dissimilarity-based models have achieved better results after selecting the
150 top-ranked genes. This behavior may be of great relevance to real-life
applications of biomedicine because the use of a smaller number of genes
allows to reduce the computational burden of the classiers and to increase
the knowledge of the relationships among genes and classes, which are in fact
two important objectives of feature selection.
Table 5: Average accuracy using the original sets of genes ( standard deviation) for the
FLD and SVM models.
FLD-F FLD-D SVM-F SVM-D
Breast 0.65770.13 0.58670.14 0.65560.15 0.62780.13
CNS 0.75480.06 0.70150.14 0.40430.16 0.70150.06
Colon 0.80950.16 0.88570.14 0.75000.20 0.54760.15
DLBCL 0.87500.17 0.94000.13 0.92000.14 0.93500.11
Lung-B 0.98330.03 1.00000.01 0.87890.06 1.00000.01
Lung-M 0.98890.04 0.97890.04 0.98890.04 0.97890.04
Prostate 0.87580.07 0.88240.06 0.88960.08 0.49230.09
Ovarian 1.00000.01 0.99600.00 1.00000.01 0.98800.02
Average 0.8692 0.8714 0.8109 0.7839
4.1. Classication results on each class
In order to visualize the accuracies on each individual class, we have also
plotted the true-positive rate (x-axis) versus the true-negative rate (y-axis)
in Fig. 5 for the Fisher's linear discriminant, Fig. 6 for the SVM and Fig. 7
for the MLP neural network, using both the feature-based (blue circles) and
the dissimilarity-based (red stars) representations. For each model, we have
depicted 150 points, each one corresponding to a subset with the top-ranked
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genes (from 1 to 150). In this manner, the best approach can be deemed as
the one that accumulates a higher number of points closest to the top-right
corner of the graph, which corresponds to the optimal classication (TPr =
1, TNr = 1).
Even though it may seem that there is not a pattern common to all the
plots, the dissimilarity-based representation has a higher quantity of points
close to the top-right corner than the feature-based representation, espe-
cially in the case of the FLD classier. This eect is particularly evident
on the Colon, DLBCL-Stanford and Prostate databases. On the contrary,
the Breast cancer database presents a rather confusing picture because the
dissimilarity-based representation generally performs better than the feature-
based FLD model, but a few number of points belonging to the feature-based
approach are closer to the top-right corner.
In Fig. 6, one can observe a certain overlapping between both representa-
tions in most databases, which makes dicult to determine whether or not
one method has been superior to the other. While the dissimilarity-based
representation seems to yield better results than the feature-based repre-
sentation on the Colon database, it performs clearly worse in the case of
the Lung-Michigan database. In fact, these results agree with the behavior
previously illustrated in Fig. 3.
Finally, the plots in Fig. 7 reveal that the behavior of the MLP neural
network is more similar to that of the Fisher's linear discriminant model
than to the one of the SVM. Although the points of the dissimilarity-based
and the feature-based representations are overlapped with each other for ve
databases, the former seems to have a larger number of points close to the
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Figure 5: True-positive rate versus true-negative rate using the FLD model with the 150
top-ranked genes.
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Figure 6: True-positive rate versus true-negative rate using the SVM classier with the
150 top-ranked genes.
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Figure 7: True-positive rate versus true-negative rate using the MLP neural network with
the 150 top-ranked genes.
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top-right corner for the remaining problems. This is especially apparent on
the Colon database, and even on the DLBCL-Stanford data.
5. Conclusion
In this work, we have proposed a methodology based on the dissimilarity
representation paradigm for classication of microarray gene expression data.
The procedure consists of two stages: rst, as a preprocessing step, the
ReliefF algorithm produces a ranking of genes according to their relevance
and a subset of the top-ranked genes is then selected; second, the training
examples dened on the lower-dimensional feature space are mapped into a
dissimilarity space, on which the corresponding classier is nally built.
The experiments have been carried out over eight benchmark databases
available in the Internet to fulll the objectives of this study, which have pri-
marily been to investigate and evaluate the classication performance of the
dissimilarity-based representation as compared to the conventional feature-
based models in the context of microarray data. To this end, we have used
the FLD, SVM and MLP classiers and estimated the overall classication
accuracy, the true-positive rate and the true-negative rate by means of a
10-fold cross-validation scheme. In addition, we have already calculated the
Friedman's ranks of classication accuracy averaged across the 150 subsets
of genes in order to ascertain whether or not the classiers built on a dissim-
ilarity space outperform those constructed on a feature space.
The reported results show that the classication models based on a dis-
similarity representation have achieved higher prediction accuracy on most
databases and almost independently of the number of genes. Among the
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three classiers here applied, it has to be noted that the Fisher's linear dis-
criminant appears to be the best performing algorithm and therefore it can
be concluded as a suitable solution for the classication of microarray gene
expression data. It is also important to remark that the dissimilarity-based
approaches appear to be more robust and less sensitive to the number of
genes selected than the feature-based classiers. Hence, we believe that our
experiments have demonstrated the potential benets of using this alterna-
tive representation paradigm in the realm of biomedical applications, as it is
the case of the classication of cancerous and normal tissue samples or the
discrimination of dierent (sub)types of tumors.
Although this preliminary study has concentrated on three linear clas-
siers, we plan on testing the proposed dissimilarity-based approach using
other prediction models that have already been applied to several biomedical
applications. In particular, we would like to extend the present study to
ensembles of classiers because these have proven to be very eective and
obtain reliable results in a number of real-life problems, including the anal-
ysis and classication of microarray data. While this work has focused on
the use of the Euclidean metric as a dissimilarity function, there are other
distance measures that could also be explored and even pseudo-Euclidean
spaces determined by an embedding procedure could be studied as well. Fi-
nally, another avenue for further research refers to the analysis of the eect
of imbalanced class distributions, missing values in genes, data sparsity and
small disjuncts on the performance of dissimilarity-based approaches, which
constitute some additional data complexities fairly common to this kind of
biomedical applications.
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